1 November 2024 false No description of principal activity Taxfiler 2024.6 15185658 business:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 15185658 2024-10-31 15185658 2024-11-01 2025-10-31 15185658 business:AuditExempt-NoAccountantsReport 2024-11-01 2025-10-31 15185658 business:FilletedAccounts 2024-11-01 2025-10-31 15185658 2025-10-31 15185658 business:Director1 2024-11-01 2025-10-31 15185658 2024-10-31 15185658 core:WithinOneYear 2025-10-31 15185658 core:WithinOneYear 2024-10-31 15185658 core:AfterOneYear 2025-10-31 15185658 core:AfterOneYear 2024-10-31 15185658 core:ShareCapital core:PreviouslyStatedAmount 2025-10-31 15185658 core:ShareCapital core:PreviouslyStatedAmount 2024-10-31 15185658 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-10-31 15185658 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-10-31 15185658 core:PreviouslyStatedAmount 2025-10-31 15185658 core:PreviouslyStatedAmount 2024-10-31 15185658 business:SmallEntities 2024-11-01 2025-10-31 15185658 countries:EnglandWales 2024-11-01 2025-10-31 15185658 core:ComputerEquipment 2024-11-01 2025-10-31 15185658 core:ComputerEquipment 2024-10-31 15185658 core:ComputerEquipment 2025-10-31 15185658 2023-10-04 2024-10-31 iso4217:GBP xbrli:pure
Company Registration No. 15185658 (England and Wales)
KHAN PHARMA LTD Unaudited accounts for the year ended 31 October 2025
KHAN PHARMA LTD Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
KHAN PHARMA LTD Company Information for the year ended 31 October 2025
Director
Mohammed Usman Khan
Company Number
15185658 (England and Wales)
- 3 -
KHAN PHARMA LTD Statement of financial position as at 31 October 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
1,545
1,884
Current assets
Debtors
5
6,315
-
Cash at bank and in hand
10,789
9,001
17,104
9,001
Creditors: amounts falling due within one year
6
(1,521)
(4,057)
Net current assets
15,583
4,944
Total assets less current liabilities
17,128
6,828
Creditors: amounts falling due after more than one year
7
12,355
12,355
Net assets
29,483
19,183
Capital and reserves
Called up share capital
1
1
Profit and loss account
29,482
19,182
Shareholders' funds
29,483
19,183
For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 11 May 2026 and were signed on its behalf by
Mohammed Usman Khan Director Company Registration No. 15185658
- 4 -
KHAN PHARMA LTD Notes to the Accounts for the year ended 31 October 2025
1
Statutory information
KHAN PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 15185658.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
18%
4
Tangible fixed assets
Computer equipment
£
Cost or valuation
At cost
At 1 November 2024
2,298
At 31 October 2025
2,298
Depreciation
At 1 November 2024
414
Charge for the year
339
At 31 October 2025
753
Net book value
At 31 October 2025
1,545
At 31 October 2024
1,884
5
Debtors
2025
2024
£
£
Amounts falling due within one year
Other debtors
6,315
-
- 5 -
KHAN PHARMA LTD Notes to the Accounts for the year ended 31 October 2025
6
Creditors: amounts falling due within one year
2025
2024
£
£
Taxes and social security
2,496
4,057
Other creditors
(975)
-
1,521
4,057
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
(12,355)
(12,355)
8
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 6 -